Tag Archives: FIRST_PUBLISH_HEADLINE | Intercept Pharmaceuticals Receives Full Letter of Response from FDA for Treatment of Fibrosis Due to NASH

Intercept Pharmaceuticals Inc. shares ICPT, -39.73% More than 30% fell in pre-market trade on Monday, after the company said it received a full response letter from the U.S. Food and Drug Administration regarding its new request for drugs for treatment. for fibrosis caused by non-alcoholic steatohepatitis, or NASH. The letter …

Intercept Pharmaceuticals Inc. shares ICPT, -2.65% More than 30% fell in pre-market trade on Monday, after the company said it received a full response letter from the U.S. Food and Drug Administration regarding its new request for drugs for treatment. for fibrosis caused by non-alcoholic steatohepatitis, or NASH. The letter …